Molecules 2013, 18(12), 15019-15034; doi:10.3390/molecules181215019
Article

Helping Eve Overcome ADAM: G-Quadruplexes in the ADAM-15 Promoter as New Molecular Targets for Breast Cancer Therapeutics

1 College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA 2 Department of Pharmacology, School of Pharmacy, The University of Mississippi, University, MS 38677, USA
* Author to whom correspondence should be addressed.
Received: 25 September 2013; in revised form: 25 November 2013 / Accepted: 26 November 2013 / Published: 5 December 2013
(This article belongs to the Special Issue G-Quadruplexes & i-Motif DNA)
PDF Full-text Download PDF Full-Text [742 KB, uploaded 5 December 2013 14:25 CET]
Abstract: ADAM-15, with known zymogen, secretase, and disintegrin activities, is a catalytically active member of the ADAM family normally expressed in early embryonic development and aberrantly expressed in various cancers, including breast, prostate and lung. ADAM-15 promotes extracellular shedding of E-cadherin, a soluble ligand for the HER2/neu receptor, leading to activation, increased motility, and proliferation. Targeted downregulation of both ADAM-15 and HER2/neu function synergistically kills breast cancer cells, but to date there are no therapeutic options for decreasing ADAM-15 function or expression. In this vein, we have examined a unique string of guanine-rich DNA within the critical core promoter of ADAM-15. This region of DNA consists of seven contiguous runs of three or more consecutive guanines, which, under superhelical stress, can relax from duplex DNA to form an intrastrand secondary G-quadruplex (G4) structure. Using biophysical and biological techniques, we have examined the G4 formation within the entire and various truncated regions of the ADAM-15 promoter, and demonstrate strong intrastrand G4 formation serving to function as a biological silencer element. Characterization of the predominant G4 species formed within the ADAM-15 promoter will allow for specific drug targeting and stabilization, and the further development of novel, targeted therapeutics.
Keywords: G-quadruplex; ADAM-15; breast cancer

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Brown, R.V.; Gaerig, V.C.; Simmons, T.; Brooks, T.A. Helping Eve Overcome ADAM: G-Quadruplexes in the ADAM-15 Promoter as New Molecular Targets for Breast Cancer Therapeutics. Molecules 2013, 18, 15019-15034.

AMA Style

Brown RV, Gaerig VC, Simmons T, Brooks TA. Helping Eve Overcome ADAM: G-Quadruplexes in the ADAM-15 Promoter as New Molecular Targets for Breast Cancer Therapeutics. Molecules. 2013; 18(12):15019-15034.

Chicago/Turabian Style

Brown, Robert V.; Gaerig, Vanessa C.; Simmons, Taesha; Brooks, Tracy A. 2013. "Helping Eve Overcome ADAM: G-Quadruplexes in the ADAM-15 Promoter as New Molecular Targets for Breast Cancer Therapeutics." Molecules 18, no. 12: 15019-15034.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert